ABSTRACT Catheter mapping during sinus rhythm was performed in 132 patients with coronary artery disease and 26 patients with congestive noncoronary cardiomyopathy. Each of the patients had a clinical history of one of the following: no ventricular arrhythmia, nonsustained ventricular tachycardia, cardiac arrest, or sustained ventricular tachycardia. The characteristics of the endocardial electrogram and other measured indexes of slow endocardial conduction were compared between patients with different types of disease and in different arrhythmia groups to determine if differences existed. The cardiomyopathic group had a higher percent of normal endocardial electrograms than the coronary artery disease group, with no evidence of slow endocardial conduction. The sustained ventricular tachycardia group exhibited a greater percent of abnormal endocardial electrograms and more evidence of slow endocardial conduction, distinguishing this group from the three other arrhythmia groups. We conclude the following: (1) No. 4, 645452, 1986. LEFT VENTRICULAR mapping in individuals in sinus rhythm has been performed in a variety of patient groups, including those with a normal left ventricle,'-' conduction defects,8-14 coronary artery disease with or without ventricular tachycardia,'2-22 and hypertrophic cardiomyopathy.23 These studies primarily described activation patterns only, although a few attempted to quantitatively and qualitatively characterize local elec-
trograms. Two of these studies 14. 17 have evaluated the possibility that characteristics of electrograms could identify an electrophysiologic substrate that would differentiate patients with ventricular tachycardia from those without tachycardia in the presence of coronary artery disease. These studies have analyzed all patients with complex ventricular ectopy, nonsustained ventricular tachycardia, sustained ventricular tachycardia, or ventricular fibrillation as one group. This failure to distinguish between patients with different ventricular arrhythmias is a possible source of error not adequately addressed. Finally, no information exists describing the characteristics of local sinus rhythm endocardial electrograms in patients with congestive noncoronary cardiomyopathy with or without ventricular arrhythmia.
This study was performed to address these issues.
cardiomyopathy to see if differences existed. In addition, an analysis was performed with the use of the same characteristics to see if differences existed based on type (or absence) of ventricular arrhythmia in patients with either coronary artery disease or noncoronary cardiomyopathy.
Methods
Patient population. One hundred fifty-eight patients referred to the Hospital of the University of Pennsylvania underwent sinus rhythm endocardial catheter mapping for either clinical or research purposes after informed written consent was obtained. All protocols have been approved by the Committee on Studies Involving Human Beings. The group consisted of 128 men and 30 women with a mean age of 58 + 10 years.
The patients were classified according to underlying heart disease based on results of history, physical examination, chest x-ray, echocardiography, radionuclide gated blood pool scan (132/158 84%) and/or coronary angiography, and left ventriculography (150/158, 95%). There were 132 patients with coronary artery disease and 26 patients with congestive noncoronary cardiomyopathy (referred to as those in the cardiomyopathy group).
The patients were classified by type of spontaneous arrhyth- Local activation time at a site was defined as the time from the onset of the surface QRS to the time at which the largest rapid deflection of the local electrogram crossed the baseline.
Total endocardial activation time was defined as the time from the earliest local activation to the latest local activation. The endocardial activation time, the duration of the longest electrogram recorded, and the presence of late electrograms were taken as indicators of slow endocardial conduction velocity.
Patients were classified by type of arrhythmia on clinical presentation and by the arrhythmia induced in the electrophysiologic laboratory. Sustained ventricular tachycardia was defined as tachycardia lasting greater than 30 sec and not causing hemodynamic collapse. Cardiac arrest was defined as ventricular fibrillation or ventricular tachycardia producing hemodynamic collapse. Nonsustained ventricular tachycardia was defined as a ventricular tachycardia of at least three complexes (non-bundle branch reentry) lasting up to 30 sec and not requiring cardioversion. All other patients were classified as having no ventricular tachycardia.
Data analysis. Electrogram amplitudes, durations, and activation times were assessed at each site by two independent observers, with a minimum of four complexes being sampled. A maximum of 12 sites per patient was used for this analysis. Thus, a mean value was used when multiple samples were obtained from any given site. All patients included in this analysis had a minimum of 75% (i.e., nine out of 12 sites) of the endocardium sampled.
All results are expressed in terms of mean + SD. The Student t test for unpaired data, the Mann-Whitney test, and R x C contingency table analysis were used as appropriate.
Results
General data. A mean of 17 ± 4 total sites, resulting in 1 1 + 1 separate (maximum 12) sites, were obtained per patient. This was equally distributed among all patient subgroups.
Fifty-six (36%) of the patients were receiving antiarrhythmic agents at the time of mapping. An R x C contingency analysis revealed a significant disproportion of patients on antiarrhythmic agents in the various groups both with respect to type of heart disease (coro- The results of this analysis led to a repeat analysis eliminating data from those patients who were receiving antiarrhythmic agents or had no previous documented myocardial infarction, thereby correcting for this possible source of bias. The analysis controlling for antiarrhythmic agents and the absence of myocardial infarction gave numerically similar results. This later analysis resulted in a smaller number of patients in some subgroups and occasionally changed the statistical power of observations. The results presented in the subsequent tables are for the entire population; all resultant changes from the later analysis are described in the tables or text.
Ejection fraction was similar in the coronary artery disease (34 + 16%) and the cardiomyopathy (34 + 13%) groups. The ejection fraction was significantly lower (p < .05) in the ventricular tachycardia group (30 ± 12%) than in the no ventricular tachycardia (40 ± 18%), nonsustained ventricular tachycardia (38 ± 17%), and cardiac arrest (37 ± 19%) groups when patients were classified by clinical arrhythmia. The ejection fraction was only significantly (p < .05) lower in the ventricular tachycardia group (30 ± 12%) than in the no ventricular tachycardia (43 ± 22%) and nonsustained ventricular tachycardia (38 ± 15%) groups when patients were classified by induced arrhythmia. These relationships remained unchanged when the type of heart disease was considered or when controlling for antiarrhythmic agents and no previous infarction.
When controlling for the presence of antiarrhythmic agents, no statistically significant differences in surface QRS duration existed between the coronary artery disease (122 ± 33 msec) and cardiomyopathy ( 120 ± 32 msec) groups, or among the no ventricular tachycardia ( 111 ± 22 msec), nonsustained ventricular tachycardia (1 16 ± 25 msec), cardiac arrest (108 + 26 msec), or ventricular tachycardia (122 ± 29 msec) groups.
Influence of underlying heart disease ( reported that signal-averaged late potentials in patients with coronary artery disease and inducible arrhythmias were related to both the number and duration of late sites recorded on the endocardium. These data suggest that the endocardium is relatively unaffected in patients with cardiomyopathy and that the electrophysiologic substrate for arrhythmias is either intramural or epicardial. Further studies with intraoperative mapping will be necessary to clarify this issue.
In contrast, in the coronary artery disease group there were substantial differences among the patients with different types of arrhythmia with respect to the results of catheter mapping. The no ventricular tachycardia and nonsustained ventricular tachycardia groups were similar, both being distinguished from the ventricular tachycardia group by the fact that there was less evidence of slow endocardial conduction. Almost no fractionated electrograms were recorded in either the no ventricular tachycardia or nonsustained ventricular tachycardia group. The cardiac arrest group appeared to have slow conduction properties intermediate between those of the no ventricular tachycardia, nonsustained ventricular tachycardia, and ventricular tachycardia groups. There was a trend for the patients in whom cardiac arrest was induced to have a shorter endocardial activation time, shorter longest electro-gram duration, and lower percent distribution of late and fractionated sites than those in whom ventricular tachycardia was induced. The cardiac arrest group was distinguished from the no ventricular tachycardia group with regard to the percent of normal and abnormal electrograms recorded. These data may suggest that an "intermediate substrate" exists in patients with cardiac arrest that is sufficiently abnormal to allow malignant tachyarrhythmias to exist, yet well enough preserved to allow rapid tachycardia rates leading to cardiac arrest. This may only be a partial explanantion because recent work from this laboratory28 failed to demonstrate a close correlation between electrogram durations and cycle length of ventricular tachycardia in patients with coronary artery disease and inducible arrhythmias.
Our data, unlike that reported previously, 12-4 failed to show the percent distribution of late electrograms to be different in any of the four arrhythmia groups. It may be that late electrograms are simply a nonspecific marker of slow conduction related to previous infarction as opposed to an arrhythmogenic substrate. This is consistent with our previous report,'8 which showed that late electrograms are not predictive of the site of origin of ventricular tachycardia.
Limitations. The technical limitations of interpreting data obtained by catheter mapping during sinus rhythm have been previously reported.7' 11. 1 18 Catheter mapping during sinus rhythm is a relatively specialized invasive technique that is not widely available. The information obtained in this study, however, may provide additional insight into risk factors for malignant ventricular arrhythmias.
A second limitation relates to the patient population. Fifty percent of the patients in this study had coronary artery disease and sustained ventricular tachycardia. The statistical power of the observations in other patient groups is therefore somewhat restricted.
Clinical implications. The technique of endocardial catheter mapping during sinus rhythm provides a method by which patients with coronary artery disease and ventricular tachycardia can be characterized and differentiated from those patients with no or nonsustained ventricular arrhythmia. Patients with coronary artery disease and inducible ventricular arrhythmias leading to cardiac arrest can be less reliably differentiated from those patients with no ventricular arrhythmia. Whether this technique can be applied to identify patients at risk for serious arrhythmias or is more useful than presently available noninvasive techniques for risk stratification was not addressed by this study. A prospective comparative trial would be indicated to resolve this question. The data suggest that patients with cardiac arrest or ventricular tachycardia and underlying coronary artery disease should not be considered as a single group for the purposes of data analysis.
Endocardial sinus rhythm catheter mapping appears less useful in patients with nonischemic cardiomyopathy. This suggests that the electrophysiologic substrate for serious ventricular tachyarrhythmias in these patients is not on or adjacent to the endocardium. Further studies with intraoperative epicardial and intramural mapping are needed to elucidate the location and features of the substrate. The present results suggest that current surgical therapy for ventricular arrhythmias in patients with coronary artery disease (i.e., therapy directed toward the endocardium) is not appropriate for patients with nonischemic cardiomyopathy.
